Test Directory

Test Code
1552
Test Name
Focal Dermal Hypoplasia
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
FDH; Goltz syndrome
Description

Focal dermal hypoplasia (FDH; MIM 305600), also known as Goltz syndrome or Goltz-Gorlin syndrome is an X-linked dominant disorder caused by mutations in the PORCN gene. PORCN encodes a putative O-acyltransferase involved in palmitoylation of Wnt signaling proteins which play important roles in embryonic development. Individuals with PORCN mutations have defects in ectodermal and mesodermal tissues. The skin, eyes, skeleton and teeth are primarily affected in patients with FDH. Typical skin findings include linear or reticular hyperpigmentation or hypopigmentation, patchy skin atrophy, hairlessness, deposition of subcutaneous fat into the dermis, papillomas of the mucosa and nail dysplasia. Eye findings include coloboma, microphthalmia, aniridia, unilateral anophthalmia, corneal opacities and cataracts. Skeletal findings include asymmetrical skeletal defects, syndactyly, brachydactyly, oligodactyly, ectrodactyly and polydactyly. Additional findings include microcephaly, cleft lip/palate, facial asymmetry, short stature, diastasis pubis and osteopathia striata. Abnormalities of the teeth include, hypodontia, oligodontia, hypoplasia of the enamel, delayed eruption and malocclusion. Kidney or urinary tract malformations including horseshoe kidney, bilateral kidney hypoplasia, hydronephrosis and bifid ureter have also been documented. Mental retardation occurs in about 15% of patients with FDH. Females represent about 90% of individuals with FDH. About 95% of the female cases and almost all male cases appear to be de novo. Most females with FDH display extreme skewing of X-chromosome inactivation. Some females and the majority of males have postzygotic de novo mutations resulting in functional mosaicism. Some male cases may be explained by a 47, XXY karyotype. The phenotype seems to be dependent, to some extent, on the degree of functional mosaicism. Because of the mosaicism, DNA sequence analysis of any one cell type may not be highly sensitive for mutation detection. The prevalence of FDH is not known.

Testing Schedule
Monday-Friday
Genes
PORCN
MIM
305600
Disease Group
Ophthalmology, Skeletal Disorders, Skin